During the past decade, Alabama Vaccine CRS conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alabama Vaccine CRS" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 20 trials, followed by "Genocea Biosciences, Inc." with 3 trials sponsored, "HIV Vaccine Trials Network" with 2 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored and "Bavarian Nordic" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alabama Vaccine CRS" #1 collaborator was "HIV Vaccine Trials Network" with 5 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "HIV Prevention Trials Network" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Alabama Vaccine CRS" are "HIV Infections" (18 trials), "Genital Herpes Simplex Type 2" (4 trials), "Avian Influenza" (2 trials), "COVID-19" (2 trials) and "Influenza Immunisation" (2 trials). Many other conditions were trialed in "Alabama Vaccine CRS" in a lesser frequency.

Most popular intervention types in "Alabama Vaccine CRS" are "Biological" (27 trials), "Other" (8 trials) and "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "VRC-HIVADV014-00-VP" (3 trials), "VRC-HIVDNA009-00-VP" (3 trials), "ALVAC(2)120(B,MN)GNP (vCP1452)" (2 trials) and "AS03" (2 trials). Other intervention names were less common.

The vast majority of trials in "Alabama Vaccine CRS" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Alabama Vaccine CRS". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Alabama Vaccine CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Alabama Vaccine CRS, 18 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".